The efficacy and safety of the addition of poly ADP-ribose polymerase (PARP) inhibitors to therapy for ovarian cancer: a systematic review and meta-analysis

by Yingzhu Yang, Nannan Du, Laidi Xie, Jing Jiang, Jiahang Mo, Jiaze Hong, Danyi Mao, Derry Minyao Ng, Huiwei Shi
Published 2020-07-01